A citation-based method for searching scientific literature

Jing Niu, Zhiping Ma, Aijiang Nuerlan, Sijing Li, Wenli Cui, Haixia Gao, Gulinaer Abulajiang, Wei Zhang, Xinxia Li. Mol Med Rep 2020
Times Cited: 5







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
R Eric Davis, Vu N Ngo, Georg Lenz, Pavel Tolar, Ryan M Young, Paul B Romesser, Holger Kohlhammer, Laurence Lamy, Hong Zhao, Yandan Yang,[...]. Nature 2010
40

Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.
Ju-Han Lee, Hoiseon Jeong, Jung-Woo Choi, HwaEun Oh, Young-Sik Kim. Sci Rep 2017
48
40

Oncogenically active MYD88 mutations in human lymphoma.
Vu N Ngo, Ryan M Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao, Kian-Huat Lim, Holger Kohlhammer, Weihong Xu, Yandan Yang, Hong Zhao,[...]. Nature 2011
40

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
881
40

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis.
Joost S Vermaat, Sebastiaan F Somers, Liesbeth C de Wreede, Willem Kraan, Ruben A L de Groen, Anne M R Schrader, Emile D Kerver, Cornelis G Scheepstra, Henriëtte Berenschot, Wendy Deenik,[...]. Haematologica 2020
35
40

CD79: a review.
P G Chu, D A Arber. Appl Immunohistochem Mol Morphol 2001
106
20

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
Wyndham H Wilson, Ryan M Young, Roland Schmitz, Yandan Yang, Stefania Pittaluga, George Wright, Chih-Jian Lih, P Mickey Williams, Arthur L Shaffer, John Gerecitano,[...]. Nat Med 2015
713
20

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Steven P Treon, Lian Xu, Guang Yang, Yangsheng Zhou, Xia Liu, Yang Cao, Patricia Sheehy, Robert J Manning, Christopher J Patterson, Christina Tripsas,[...]. N Engl J Med 2012
806
20

A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
James D Phelan, Ryan M Young, Daniel E Webster, Sandrine Roulland, George W Wright, Monica Kasbekar, Arthur L Shaffer, Michele Ceribelli, James Q Wang, Roland Schmitz,[...]. Nature 2018
180
20

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.
George Wright, Bruce Tan, Andreas Rosenwald, Elaine H Hurt, Adrian Wiestner, Louis M Staudt. Proc Natl Acad Sci U S A 2003
730
20

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Tina Marie Green, Ken H Young, Carlo Visco, Zijun Y Xu-Monette, Attilio Orazi, Ronald S Go, Ole Nielsen, Ole V Gadeberg, Torben Mourits-Andersen, Mikael Frederiksen,[...]. J Clin Oncol 2012
482
20

B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.
Gero Knittel, Paul Liedgens, Darya Korovkina, Jens M Seeger, Yussor Al-Baldawi, Mona Al-Maarri, Christian Fritz, Katerina Vlantis, Svetlana Bezhanova, Andreas H Scheel,[...]. Blood 2016
76
20

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.
Michail S Lionakis, Kieron Dunleavy, Mark Roschewski, Brigitte C Widemann, John A Butman, Roland Schmitz, Yandan Yang, Diane E Cole, Christopher Melani, Christine S Higham,[...]. Cancer Cell 2017
288
20

Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.
Sylvain Mareschal, Anne Pham-Ledard, Pierre Julien Viailly, Sydney Dubois, Philippe Bertrand, Catherine Maingonnat, Maxime Fontanilles, Elodie Bohers, Philippe Ruminy, Isabelle Tournier,[...]. J Invest Dermatol 2017
65
20

Aggressive lymphomas.
Georg Lenz, Louis M Staudt. N Engl J Med 2010
426
20

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
Andreas Rosenwald, George Wright, Wing C Chan, Joseph M Connors, Elias Campo, Richard I Fisher, Randy D Gascoyne, H Konrad Muller-Hermelink, Erlend B Smeland, Jena M Giltnane,[...]. N Engl J Med 2002
20

Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.
Andres Forero-Torres, Radhakrishnan Ramchandren, Abdulraheem Yacoub, Michael S Wertheim, William J Edenfield, Paolo Caimi, Martin Gutierrez, Luke Akard, Carolina Escobar, Justin Call,[...]. Blood 2019
52
20

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Anupama Reddy, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg,[...]. Cell 2017
561
20

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert,[...]. Nat Med 2018
754
20

Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.
Ryan M Young, Tianyi Wu, Roland Schmitz, Moez Dawood, Wenming Xiao, James D Phelan, Weihong Xu, Laurence Menard, Eric Meffre, Wing-Chung C Chan,[...]. Proc Natl Acad Sci U S A 2015
107
20

CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase.
Alessio Montresor, Lara Toffali, Antonella Rigo, Isacco Ferrarini, Fabrizio Vinante, Carlo Laudanna. Oncotarget 2018
15
20

Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.
Elodie Bohers, Pierre-Julien Viailly, Stéphanie Becker, Vinciane Marchand, Philippe Ruminy, Catherine Maingonnat, Philippe Bertrand, Pascaline Etancelin, Jean-Michel Picquenot, Vincent Camus,[...]. Blood Cancer J 2018
53
20

Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.
Kohei Taniguchi, Katsuyoshi Takata, Shih-Sung Chuang, Tomoko Miyata-Takata, Yasuharu Sato, Akira Satou, Yuko Hashimoto, Maiko Tamura, Keina Nagakita, Nobuhiko Ohnishi,[...]. Am J Surg Pathol 2016
32
20

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.
Jens G Lohr, Petar Stojanov, Michael S Lawrence, Daniel Auclair, Bjoern Chapuy, Carrie Sougnez, Peter Cruz-Gordillo, Birgit Knoechel, Yan W Asmann, Susan L Slager,[...]. Proc Natl Acad Sci U S A 2012
708
20

MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome.
Jordina Rovira, Kennosuke Karube, Alexandra Valera, Dolors Colomer, Anna Enjuanes, Lluís Colomo, Alejandra Martínez-Trillos, Eva Giné, Ivan Dlouhy, Laura Magnano,[...]. Clin Cancer Res 2016
39
20

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.
Anne M R Schrader, Patty M Jansen, Rein Willemze, Maarten H Vermeer, Anne-Marie Cleton-Jansen, Sebastiaan F Somers, Hendrik Veelken, Ronald van Eijk, Willem Kraan, Marie José Kersten,[...]. Blood 2018
44
20

MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphoma.
C Fernández-Rodríguez, B Bellosillo, M García-García, B Sánchez-González, E Gimeno, M C Vela, S Serrano, C Besses, A Salar. Leukemia 2014
44
20

CD79B and MYD88 mutations in diffuse large B-cell lymphoma.
Yuil Kim, Hyunjeong Ju, Dong Hoon Kim, Hae Yong Yoo, Suk Jin Kim, Won Seog Kim, Young Hyeh Ko. Hum Pathol 2014
40
20

Tonic Signals: Why Do Lymphocytes Bother?
Darienne R Myers, Julie Zikherman, Jeroen P Roose. Trends Immunol 2017
52
20

Receptor-specific induction of NF-kappaB components in primary B cells.
D A Francis, R Sen, N Rice, T L Rothstein. Int Immunol 1998
33
20

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Nathalie A Johnson, Graham W Slack, Kerry J Savage, Joseph M Connors, Susana Ben-Neriah, Sanja Rogic, David W Scott, King L Tan, Christian Steidl, Laurie H Sehn,[...]. J Clin Oncol 2012
661
20

Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease.
Jacquelyn R Bedsaul, Nicole M Carter, Katelynn E Deibel, Shelby M Hutcherson, Tyler A Jones, Zhaoquan Wang, Chao Yang, Yong-Kang Yang, Joel L Pomerantz. Front Immunol 2018
41
20

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
William W L Choi, Dennis D Weisenburger, Timothy C Greiner, Miguel A Piris, Alison H Banham, Jan Delabie, Rita M Braziel, Huimin Geng, Javeed Iqbal, Georg Lenz,[...]. Clin Cancer Res 2009
470
20


Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.
Mara Compagno, Wei Keat Lim, Adina Grunn, Subhadra V Nandula, Manisha Brahmachary, Qiong Shen, Francesco Bertoni, Maurilio Ponzoni, Marta Scandurra, Andrea Califano,[...]. Nature 2009
775
20

Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
Keisuke Horikawa, Stephen W Martin, Sarah L Pogue, Karlee Silver, Kaiman Peng, Kiyoshi Takatsu, Christopher C Goodnow. J Exp Med 2007
106
20


The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid.
Laura S Hiemcke-Jiwa, Monique C Minnema, Joyce H Radersma-van Loon, N Mehdi Jiwa, Mirthe de Boer, Roos J Leguit, Roel A de Weger, Manon M H Huibers. Hematol Oncol 2018
60
20

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.
Christian Grommes, Alessandro Pastore, Nicolaos Palaskas, Sarah S Tang, Carl Campos, Derrek Schartz, Paolo Codega, Donna Nichol, Owen Clark, Wan-Ying Hsieh,[...]. Cancer Discov 2017
207
20

Src-family kinases in B-cell development and signaling.
Stephen B Gauld, John C Cambier. Oncogene 2004
105
20

CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
Ichiro Yonese, Hiroshi Takase, Mayumi Yoshimori, Erika Onozawa, Akiho Tsuzura, Tohru Miki, Manabu Mochizuki, Osamu Miura, Ayako Arai. Eur J Haematol 2019
36
20

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.
W Kraan, H M Horlings, M van Keimpema, E J M Schilder-Tol, M E C M Oud, C Scheepstra, P M Kluin, M J Kersten, M Spaargaren, S T Pals. Blood Cancer J 2013
134
20

MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications.
Ruben A L de Groen, Anne M R Schrader, Marie José Kersten, Steven T Pals, Joost S P Vermaat. Haematologica 2019
27
20

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies.
Andreas Agathangelidis, Nikos Darzentas, Anastasia Hadzidimitriou, Xavier Brochet, Fiona Murray, Xiao-Jie Yan, Zadie Davis, Ellen J van Gastel-Mol, Cristina Tresoldi, Charles C Chu,[...]. Blood 2012
279
20


Molecular outcome prediction in diffuse large-B-cell lymphoma.
Ash A Alizadeh, Andrew J Gentles, Izidore S Lossos, Ronald Levy. N Engl J Med 2009
16
20

Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen.
D J Lenschow, A I Sperling, M P Cooke, G Freeman, L Rhee, D C Decker, G Gray, L M Nadler, C C Goodnow, J A Bluestone. J Immunol 1994
261
20

Marginal zone lymphomas and infectious agents.
Andrés J M Ferreri, Silvia Govi, Maurilio Ponzoni. Semin Cancer Biol 2013
53
20

Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia.
Irene M Ghobrial, Thomas E Witzig, Morie Gertz, Betsy LaPlant, Suzanne Hayman, John Camoriano, Martha Lacy, P Leif Bergsagel, Stacey Chuma, Daniel DeAngelo,[...]. Am J Hematol 2014
51
20

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.
Stuart E Lacy, Sharon L Barrans, Philip A Beer, Daniel Painter, Alexandra G Smith, Eve Roman, Susanna L Cooke, Camilo Ruiz, Paul Glover, Suzan J L Van Hoppe,[...]. Blood 2020
129
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.